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Campylobacter jejuni is one of the major causes of infectious diarrhea world-wide, although relatively little is know
about its mechanisms of pathogenicity. This bacterium can gain entry into intestinal epithelial cells, which is thought
to be important for its ability to persistently infect and cause disease. We found that C. jejuni is able to survive within
intestinal epithelial cells. However, recovery of intracellular bacteria required pre-culturing under oxygen-limiting
conditions, suggesting that C. jejuni undergoes significant physiological changes within the intracellular environment.
We also found that in epithelial cells the C. jejuni–containing vacuole deviates from the canonical endocytic pathway
immediately after a unique caveolae-dependent entry pathway, thus avoiding delivery into lysosomes. In contrast, in
macrophages, C. jejuni is delivered to lysosomes and consequently is rapidly killed. Taken together, these studies
indicate that C. jejuni has evolved specific adaptations to survive within host cells.
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Introduction
Campylobacter jejuni is the leading cause of bacterial food-
borne illness in the United States and a major cause of
diarrheal disease throughout the world [1]. C. jejuni infection
is also an important pre-condition for Guillain-Barre ´
paralysis [2]. Despite its public health importance, relatively
little is known about its pathogenesis. Examination of
intestinal biopsies of humans [3], in vivo studies in infected
primates [4] and other animal models [5–7], together with in
vitro experiments using cultured human intestinal epithelial
cells [8–10], have demonstrated that C. jejuni can invade non-
phagocytic intestinal epithelial cells. However, to date, little is
known about the molecular details of the mechanisms by
which C. jejuni enters intestinal epithelial cells. Bacterial
factors such as motility, glycosylation, and capsular synthesis
have been implicated in C. jejuni internalization [11–14].
Strains with mutations in these pathways have defects in their
ability to adhere to and invade host cells, as well as to colonize
animals [12–19]. Bacterial invasion has also been correlated
with C. jejuni’s ability to stimulate the activation of MAP
kinases leading to the production of the pro-inﬂammatory
cytokine, IL-8 [20,21]. Taken together, these data suggest that
bacterial internalization into intestinal epithelial cells is
important in C. jejuni pathogenesis.
Although most host factors that are required for C. jejuni
internalization into non-phagocytic cells remain unknown,
this entry process appears to have unique cytoskeletal
requirements. Most other bacterial pathogens such as Listeria
monocytogenes, Shigella ﬂexneri, and Salmonella typhimurium utilize
the host-cell actin cytoskeleton to gain intracellular access
[22]. However, C. jejuni is internalized into intestinal epithelial
cells in a microtubule-dependent, actin-independent fashion
[10], suggesting that this bacterium employs an entry
mechanism unlike those reported for other bacterial patho-
gens.
T h ei n t r a c e l l u l a rf a t eo fC. jejuni remains unknown,
although it is likely that this bacterium, similar to other
intracellular pathogens, may have evolved speciﬁc adapta-
tions to survive within host cells. Intracellular pathogens
utilize a variety of strategies to survive and replicate within
host cells. For example, some pathogens such as Trypanasoma
cruzi [23], Listeria monocytogenes [24], and Shigella ﬂexneri [22,25]
break out of the phagocytic vacuoles after internalization and
can replicate within the cytosol of the infected cell. Other
pathogens, such as Leishmania, have evolved an array of
adaptations to survive in the hostile environment of the
phagolysosome, which is characterized by low oxygen tension,
poor nutrient content, low pH, and the presence of a variety
of antibacterial products such as antibacterial peptides and
lysosomal enzymes [26]. Yet another group of intracellular
pathogens survive within a vesicular compartment that does
not fuse with lysosomes. For example, Salmonella typhimurium
[27] and Mycobacterium tuberculosis [28] alter the biogenesis and
dynamics of their vacuolar compartment preventing fusion to
lysosomes.
All evidence to date indicates that after internalization
into intestinal epithelial cells, C. jejuni resides within a
membrane bound compartment [29–31]. We report here
that C. jejuni survives within intestinal epithelial cells by
deviating from the canonical endocytic pathway thus residing
in a unique intracellular compartment that does not fuse
with lysosomes.
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Campylobacter jejuni Survives within Intestinal Epithelial
Cells but Not within Bone Marrow–Derived Macrophages
Although C. jejuni internalization into host cells is believed
to play a role in pathogenesis, little is known about its
intracellular fate. We therefore examined the ability of C.
jejuni to survive within intestinal epithelial cells. Human
intestinal epithelial T84 cells were infected with C. jejuni, and
total viable intracellular bacteria were determined at differ-
ent times by counting colony forming units (CFU). Signiﬁcant
numbers of CFU (. 3310
5/well) were recovered at early time
points, however, over time, the number of CFU recovered
decreased considerably (Figure 1A). By 24 h there was a ;500-
fold decrease in the number of CFU recovered from infected
cells compared to 4 h after infection (Figure 1A). These
results suggest that intracellular C. jejuni rapidly loses viability
during the course of its intracellular stage. This was
surprising as it suggested that the ability of C. jejuni to enter
non-phagocytic cells might not confer a signiﬁcant advantage
to this bacterium. We therefore examined the possibility that
internalized C. jejuni may alter its physiology in such a way
that, although viable, it may not be culturable under the
conditions used in this assay. Indeed, C. jejuni has been
reported to enter a viable but non-culturable state when
subjected to a variety of stimuli or environments [32–34]. To
address this issue, we stained C. jejuni recovered from cultured
intestinal T84 cells with reagents that distinguish viable from
non-viable bacteria (see Materials and Methods). Using these
reagents, we observed no decrease in viability of intracellular
C. jejuni over time (Figure 1B and 1C). In fact, FACS analysis
also revealed that the ratio of viable to non-viable bacteria
did not change over the course of infection (Figure 1C and
1D). These results indicate that C. jejuni remains viable for at
least 24 h after infection and suggest that it acquires a
physiological state that does not allow the recovery of CFU
under our standard culture conditions. We hypothesized that
once internalized by intestinal epithelial cells, C. jejuni might
adapt to the low oxygen environment within the cell by
changing its mode of respiration. We therefore tested
whether the intracellular bacterial population could be
cultured if allowed to ‘‘recover’’ under conditions in which
oxygen is very limiting. Human intestinal epithelial T84 cells
were infected with C. jejuni and the number of CFU was
determined after culturing under oxygen-limiting incubation
or under 10% CO2 conditions. The number of CFU decreased
drastically (;500 fold) when bacteria were directly grown
under an atmosphere of 10% CO2 (Figure 2A) or in GasPak
jars (BBL Microbiology Systems, Cockeysville, MD) with BBL
CampyPacks (BBL Microbiology Systems, Cockeysville, MD)
(data not shown). However, there was no signiﬁcant decrease
in the number of CFU recovered over time when the plates
were incubated under oxygen-limiting conditions for 48 h
and then switched to an atmosphere of 10% CO2 (Figure 2A).
The number of CFU recovered when plates where pre-
incubated under low-oxygen conditions closely correlated
with the number of viable bacteria quantiﬁed via FACS
analysis (Figure 2B). These data demonstrate that C. jejuni
remains viable within intestinal epithelial cells for at least 24
h, although it undergoes physiological changes such that
requires exposure to oxygen-limiting conditions for its
efﬁcient recovery.
There are contradictory reports regarding the ability of C.
jejuni to survive within macrophages [29,35–38]. Given our
ﬁndings in intestinal epithelial cells suggesting physiological
changes in intracellular C. jejuni, which affects its ability to be
cultured, we re-examined its ability to survive within macro-
phages. Mouse primary bone marrow–derived macrophages
(BMDM) were infected with C. jejuni and the number of CFU
recovered over time was determined by incubating culture
plates directly under either 10% CO2 or subjecting them to a
48 h pre-incubation under oxygen-limiting conditions prior
to incubation under 10% CO2. We found a signiﬁcant
decrease in the number of CFU recovered over time
regardless of the culture condition. By 12 h there was a
severe reduction in the number of CFU recovered under both
10% CO2 or with pre-incubation under oxygen-limiting
conditions (.2,000 and .100 fold, respectively, compared
to the CFU recovered 1 h after infection) (Figure 2C), and no
CFU were recovered at 24 h of infection regardless of the
culture conditions. Taken together, these data demonstrate
that intracellular C. jejuni can survive within intestinal
epithelial cells but are killed by professional phagocytes.
C. jejuni Avoids Delivery to Lysosomes in Epithelial Cells
Immediately after internalization into host cells, C. jejuni
resides within a membrane bound compartment [29–31]. It is
therefore possible that in order to survive within cells, this
bacterium has evolved speciﬁc adaptations to survive within
lysosomes or to modulate host cellular trafﬁcking events to
avoid fusion with lysosomes. If C. jejuni survives within
lysosomes, the C. jejuni–containing vacuole (CCV) should be
accessible to endocytic tracers. To test this hypothesis, Cos-1
cells were ﬁrst infected with C. jejuni and subsequently
exposed to the ﬂuorescent endocytic tracer dextran, which
was chased into lysosomes. As a control, cells were infected
with a strain of S. typhimurium carrying a mutation in invA and
a plasmid expressing the Yersinia pseudotuberculosis protein
invasin. InvA is an essential component of the invasion-
associated type III secretion system [39] and therefore this
strain enters cells through the invasin-mediated pathway [40].
Subsequent to its uptake, the invasin-expressing bacteria is
delivered to lysosomes (Watson and Gala ´n, unpublished
data). Immunoﬂuorescense microscopy analysis revealed that
90% of the vacuoles containing S. typhimurium invA (invasin)
colocalized with the endocytic tracer dextran (Figure 3A and
Figure S1). In contrast, only ;15% of the C. jejuni–containing
vacuoles acquired detectible amounts of dextran (Figure 3A
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Author Summary
Campylobacter jejuni is one of the most common causes of food-
borne illness in the United States and a major cause of diarrheal
disease throughout the world. After infection through the oral route,
this bacterium invades the cells of the intestinal epithelium, a
property that is important for its ability to cause disease. Usually,
bacteria and other material entering the cell move to compartments
called lysosomes, where an acidic mix of enzymes breaks it down.
This study shows that C. jejuni can survive within intestinal epithelial
cells by avoiding delivery to lysosomes. In contrast, in macrophages,
which are specialized cells with the capacity to engulf and kill
bacteria, C. jejuni cannot avoid delivery into lysosomes and
consequently is rapidly killed. These studies help explain an
important virulence attribute of C. jejuni.and Figure S1). These data suggest that the CCV is function-
ally separated from the canonical endocytic pathway. To
conﬁrm these results, we used another endocytic tracer, gold-
labeled bovine serum albumin (BSA-gold) [41]. Cos-1 cells
were ﬁrst infected with C. jejuni or S. typhimurium invA
(invasin) and subsequently exposed to BSA-gold, which was
chased into lysosomes (see Materials and Methods). BSA-gold
was then imaged using electron microscopy to determine if
the CCV was accessible to this ﬂuid phase endocytic tracer.
Although BSA-gold colocalized with ;75% of the vacuoles
containing S. typhimurium invA (invasin) (Figure 3B, 3C and
3I), only 15% of the CCVs were accessible to the endocytic
marker (Figure 3D, 3E and 3I). Furthermore, the CCVs that
colocalized with BSA-gold appeared to be morphologically
different from the CCVs that did not. The CCVs accessible to
the endocytic tracer were spacious and contained additional
electron dense materials, closely resembling lysosomes
(Figure 3F). In contrast, the CCVs that did not colocalize
with BSA gold had tight membranes around the bacteria and
the compartments did not resemble lysosomes (Figure 3D
and 3E). These data conﬁrm the results obtained using
ﬂuorescence microscopy and provide additional evidence
that the CCV is segregated from the canonical endocytic
pathway.
Since our experiments established that C. jejuni quickly
loses viability within macrophages, we hypothesized that in
these cells this bacterium may be delivered to lysosomes. To
test this hypothesis, BMDM were infected with C. jejuni and
then incubated with media containing BSA-gold and exam-
ined by electron microscopy as described in Materials and
Methods. In contrast to what we observed in epithelial cells,
in macrophages over 90% of the CCVs were readily accessible
to the endocytic tracer (Figure 3G, 3H and 3I). Similar results
were obtained using ﬂuorescent dextran as an endocytic
tracer (data not shown). Taken together, these data indicate
that in macrophages, C. jejuni is delivered to lysosomes where
it cannot survive, while in intestinal epithelial cells C. jejuni is
segregated from an endocytic pathway leading to lysosomes
and consequently survives in a vacuolar compartment that is
distinct from lysosomes.
Figure 1. Survival of C. jejuni within Cultured Intestinal Epithelial Cells
Human intestinal epithelial T84 cells were infected with C. jejuni and viable intracellular bacteria were assessed over time by CFU recovery (A and B) or
live/dead staining (B–D).
(A) Viable CFU of intracellular C. jejuni were determined at the indicated times after gentamicin treatment. (B) Viable intracellular C. jejuni was analyzed
at the indicated times via CFU recovery as in A or live/dead staining and FACS analysis as described in the Materials and Methods. (C) Epiflourescent
visualization of a representative field of intracellular C. jejuni isolated at 4 h and 24 h post-infection and subjected to live (green)/dead (red) staining. (D)
Intracellular C. jejuni was isolated at different times after infection and the number of viable and non-viable intracellular bacteria was quantified via live/
dead staining and FACS analysis. Values are expressed as percent of live bacteria. In all cases, values are the mean and standard deviation of three
independent experiments.
doi:10.1371/journal.ppat.0040014.g001
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jejuni’s Ability to Survive Intracellularly
We next examined whether avoidance of lysosomal delivery
was essential for C. jejuni survival within epithelial cells. To
this end, we carried out an experiment in which C. jejuni was
internalized via the Fc receptor, a pathway known to lead to
lysosomes [42]. Cos-1 cells expressing the murine Fc receptor
were infected with either opsonized or non-opsonized C.
jejuni and at different times after infection the CFU were
determined by plating under the permissive oxygen-limiting
conditions and further incubation in 10% CO2 environment.
As shown in Figure 4A, the relative number of CFU recovered
from cells infected with opsonized C. jejuni 24 h after
infection was signiﬁcantly (. 20 fold) lower than the number
of CFU recovered from cells infected with non-opsonized
bacteria. These results indicate that internalization via the Fc
receptor results in a signiﬁcant loss of intracellular viability,
presumably because these bacteria are ultimately delivered to
lysosomes. To conﬁrm this hypothesis, we examined whether
C. jejuni internalized via the Fc receptor was accessible to an
endocytic tracer. Cos-1 cells expressing the mouse Fc
receptor were infected with opsonized C. jejuni and sub-
sequently exposed to ﬂuorescent dextran. Consistent with the
hypothesis that the loss of viability of C. jejuni internalized via
the Fc receptor was due to its delivery to lysosomes, .80% of
the opsonized bacteria colocalized with ﬂuorescent dextran,
compared to ;20% of non-opsonized control (Figure 4B).
Taken together, these data show that C. jejuni is unable to
survive within lysosomes and further indicate that this
bacterium has evolved a mechanism to avoid delivery to this
compartment in order to survive within intestinal epithelial
cells. Furthermore, these results also indicate that the
mechanism of bacterial entry into host cells has a major
impact in the ability of C. jejuni to survive intracellularly.
Acquisition of Endocytic Markers by the C. jejuni–
Containing Vacuole
To investigate the biogenesis and trafﬁcking of the CCV, we
examined the dynamics of acquisition of both early and late
endosomal markers. Cos-1 cells were infected as described in
Materials and Methods and at different times after infection
the presence of different endocytic markers was probed by
immunoﬂuorescence microscopy using speciﬁc antibodies.
Figure 2. C. jejuni Remains Viable within Intestinal Epithelial Cells but Does Not Survive within Bone Marrow–Derived Macrophages
(A) Human intestinal epithelial T84 cells were infected with C. jejuni, and viable intracellular bacteria were assessed over time by CFU recovery under
10% CO2 or oxygen-limiting conditions as described in Materials and Methods. (B) The number of viable intracellular bacteria was analyzed in parallel
via CFU recovery plated under oxygen-limiting conditions or live/dead staining coupled with FACS analysis. (C) Mouse bone marrow–derived
macrophages were infected with C. jejuni and viable bacteria CFU were determined over time after 10% CO2 or oxygen-limiting cultivation. All values
are the mean and standard deviation of three independent determinations.
doi:10.1371/journal.ppat.0040014.g002
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intracellular bacteria co-localized with the early endosomal
marker EEA-1 (Figure 5A and Figure S2). However, by 60 min,
only ;20% of the CCV co-localized with EEA-1 and more
than 80% were stained by an antibody directed to the late
endosomal marker lamp-1 (Figure 5B and Figure S2). Two
hours after infection, almost all CCVs stained with lamp-1.
The acquisition of lamp-1 may therefore occur via an
alternative pathway since, as shown above, the CCV does
not fuse with lysosomes.
In an effort to better understand the nature of the C. jejuni
compartment, we tested the CCV for the presence of other
Figure 3. The C. jejuni–Containing Vacuole Is Accessible to Endocytic Tracers in Macrophages but Not in Epithelial Cells
(A) Cos-1 cells were infected with S. typhimurium invA (invasin) expressing the dsRed protein or C. jejuni, pulsed with the endocytic tracers dextran to
label lysosomes, and phagosomes containing bacteria that colocalized with endocytic tracer were quantified. Results are the means and standard
deviation of three independent experiments. For each experiment, at least 100 phagosomes were counted. Alternatively, infected cells were pulsed
with the endocytic tracer BSA-gold and visualized by electron microscopy. Electron micrographs of phagosomes containing S. typhimurium invA
(invasin) (B and C) or C. jejuni (D, E and F) are shown. C. jejuni–containing vacuoles (CCVs) that do not colocalize with BSA-gold (D and E) as well CCVs
that colocalize with BSA-Gold and resemble lysosomes (F) are shown for comparison (see text). In addition, bone marrow–derived macrophages were
infected with C. jejuni and pulsed with BSA-gold and visualized by electron microscopy. Electron micrographs of phagosomes containing C. jejuni are
shown (G and H). Arrows indicate BSA-gold. Higher magnifications of the indicated insets are also shown to the right of each electron micrograph.
Quantification of the colocalization of BSA-gold with bacterial vacuoles in the different cells are shown (I). Results are representative of two
independent experiments in which at least 50 vacuoles were counted for colocalization with BSA-gold.
doi:10.1371/journal.ppat.0040014.g003
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C. jejuni Intracellular Survivalmarkers of the early and late endocytic pathway. We found
that early in infection, 65–70% of the CCVs co-localized with
the early endosomal markers Rab4, Rab5, and with a probe
for phosphoinisitide 3 phosphate (green ﬂuorescent protein
fused to the PX domain of the 40 kD subunit of the
nicotinamide adenine nucleotide phosphate oxidase) (Figure
5B-5D, Figure S3 and Video S1). Two hours after infection,
less than 10% of the CCVs colocalized with any of these
markers indicating that the CCV interacts transiently with
these compartments (Figure 5B-5D). Furthermore, C. jejuni
transiently acquires the late endosomal marker Rab7 (Figure
5E, 5F and Figure S4). At 45 min after infection, ;65% of
CCVs acquired Rab7-GFP, while at 2 h, only ;20% of CCVs
colocalized with Rab7-GFP. However, consistent with the
observation that the mature CCV does not co-localize with
endocytic tracers, the lysosomal marker cathepsin B was seen
in only a very small proportion of the CCVs, even at 2 h after
infection (Figure 5H and Figure S4), although it was present
in 95% of vacuoles containing S. tyhimurium invA (invasin)
(Figure 5G and Figure S4). These data further indicate that C.
jejuni survives within a unique intracellular compartment that
despite harboring the lamp-1 protein, is functionally distinct
from lysosomes.
Our results indicate that at some point after internal-
ization, the CCV deviates from the canonical endocytic
pathway. Therefore, we set out to determine at what stage
of the endocytic pathway this segregation might occur. The
GTPases Rab5 and Rab7 are involved in the biogenesis of
early and late endosomes, respectively [43]. Overexpression of
dominant negative forms of these GTPases disrupt temporal
and spatial delivery of internalized cargo to lysosomes [43].
To determine if acquisition of lamp-1 by the CCV required
Rab5 or Rab7, Cos-1 cells were transfected with wild type or
dominant negative forms of Rab5 (Rab5
S34N)o rR a b 7
(Rab7
N125I). The transfected cells were infected with C. jejuni
and the acquisiton of lamp-1 by the CCV was assessed by
immunoﬂuorescence microscopy. As a control, a similar
experiment was conducted using S. typhimurium invA (invasin),
which trafﬁcs to lysosomes. Overexpression of Rab5
S34N and
Rab7
N125I did not affect lamp-1 acquisition by the CCV,
although it effectively prevented acquisition of this marker by
the vacuoles containing S. typhimurium invA (invasin) (Figure 6
and Figure S5). These results demonstrate that the CCV
acquires lamp-1 by an alternative pathway apparently
segregating from the canonical endocytic pathway early after
C. jejuni internalization.
Caveolae and Caveolin-1 Are Required for Efficient C.
jejuni Entry into Epithelial Cells
Collectively, our data suggest that the mechanism by which
C. jejuni enters epithelial cells may ultimately determine its
intracellular fate. Although internalization through Fc
receptors delivers C. jejuni to lysosomes, when entering via
its own speciﬁc adaptations C. jejuni segregates from the
endocytic pathway and avoids delivery to lysosomes. The
mechanisms of C. jejuni internalization are unusual in that
they do not require the actin cytoskeleton and are dependent
on microtubules [10]. In fact, disruption of the actin
cytoskeleton increases the efﬁciency of bacterial uptake
(Figure S6). Previous studies have shown that addition of
ﬁlipin, an agent that sequesters cholesterol, decreased the
ability of C. jejuni to enter into cultured epithelial cells [44,45],
suggesting that lipid rafts or caveolae may be required for
efﬁcient entry into cells. Consistent with this observation, we
found that addition of the cholesterol-sequestering agent
methyl-beta cyclodextrin (MbCD) blocked C. jejuni internal-
ization into T84 in a dose-dependent manner (Figure S6).
Similar results were obtained with Cos-1 cells (data not
shown). To further investigate the potential involvement of
lipid rafts or caveolae in C. jejuni internalization, we examined
the CCV for the acquisition of caveolin-1 and ﬂotillin-1, two
markers associated with these membrane domains [46–49].
Cos-1 cells were transfected with plasmids encoding GFP-
tagged forms of caveolin-1 or ﬂotillin-1, and the association
of these markers with the CCV was examined by time lapse
and ﬂuorescence microscopy as described in Materials and
Methods. C. jejuni acquired caveolin-1-GFP and ﬂotillin-1-GFP
immediately after internalization (Figure 7A and 7B).
Quantiﬁcation of this association determined that at early
time points during infection, ;60% of the CCVs colocalized
with both caveolin-1-GFP (Figure 7C) and ﬂotillin-1-GFP
(Figure 7D and Video S2). The association, however, was
transient since at later points after infection ,10% of the
CCVs were seen in association with these markers (Figure 7C
and 7D). Vesicles devoid of bacteria but labeled by ﬂotillin-1-
GFP were also observed immediately after C. jejuni internal-
ization, and some of them eventually fused with the nascent
CCV (Video S3 and S4).
Caveolin-1 and ﬂotillin-1 have been shown to be involved
in various endocytic events, including the internalization of
microbial pathogens [50]. We therefore further examined the
potential involvement of caveolin-1 or ﬂotillin-1 in C. jejuni
internalization into non-phagocytic cells. Depletion of
ﬂotillin-1 by siRNA did not result in a measurable decrease
in the abiliy of C. jejuni to enter cells (p ¼ 0.13) (Figure S7).
Figure 4. C. jejuni Does Not Survive within Epithelial Cell Lysosomes
(A) Cos-1 cells were transfected with a plasmid expressing the Fc-
receptor. Twenty-four hours after transfection, cells were infected with
opsonized or non-opsonized C. jejuni and bacterial loads quantified over
time by culturing under oxygen-limiting permissive conditions. Values
are the mean and standard deviation of three independent experiments
and are expressed as relative CFU where the number of CFU at each time
point was normalized to the initial number of internalized bacteria,
which was considered to be 1. (B) The accessibility of the C. jejuni–
containing vacuole to the endocytic tracer in transfected cells six hours
after infection was assessed by enumeration of colocalization of C. jejuni
with dextran as described in Materials and Methods. Results are the
means and standard deviation of three independent experiments.
doi:10.1371/journal.ppat.0040014.g004
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caveolin-1 (caveolin-1
Y14F) signiﬁcantly decreased C. jejuni
internalization (p ¼ 0.02) (Figure 7E). Taken together these
data indicate that caveolin-stabilized lipid membrane do-
mains (i.e., caveolae) are important for C. jejuni efﬁcient entry
into non-phagocytic cells.
The GTPase dynamin is involved in pinching off of the
nascent endosome in both clathrin- and caveolae-mediated
endocytosis [51–54]. We therefore tested the potential
involvement of dynamin II in C. jejuni internalization. Cos-1
cells were transfected with a plasmid expressing a dominant
negative form of dynamin II (dynII
K44A), which has been
shown to inhibit both clathrin and caveolae-dependent
endocytosis [52–54], and the ability of C. jejuni to enter those
cells was examined by ﬂuorescence microscopy as described
in Materials and Methods. Although expression of dynII
K44A-
GFP effectively blocked the uptake of transferrin (data not
shown), it did not inhibit the uptake of C. jejuni (Figure 7F). In
fact, there was a modest enhancement of C. jejuni internal-
ization in the presence of wild-type dynamin II. These results
indicate that the role of caveolin-1 C. jejuni entry into cells
may not be related to its role in caveolae-mediated
endoyctosis. Rather, caveolin-1 or caveolae may play a role
in the signaling events leading to bacterial uptake, perhaps by
facilitating the spatial organization of critical signaling
molecules. In fact, tyrosine kinases have been reported to
be essential for C. jejuni entry into host cells [44,45,55], a result
that we have conﬁrmed (Figure S6). Since efﬁcient signaling
through receptor tyrosine kinases is known to require lipid
rafts or caveolae, it is possible that the inhibitory effect of
cholesterol sequestering agents or dominant negative cav-
eolin-1 may be the result of interference with tyrosine kinase
signaling.
The C. jejuni–Containing Vacuole Localizes in Close
Proximity to the Golgi
Examination of the localization of the CCV over time
showed that at 4–5 h after infection, C. jejuni localized to the
perinuclear region [56]. To gain more insight into the speciﬁc
localization of the CCV in relation to other organelles, we
investigated by immunoﬂurescence microscopy the position
of the CCV in relation to the Golgi apparatus over time using
an antibody directed against GM130, a Golgi resident protein.
Two hours after infection, intracellular C. jejuni were evenly
distributed around the cell (Figure 8A). However by 6–8 h of
infection, .85% of the CCVs were seen in close association
with the Golgi apparatus (Figure 8B and 8E), close to the
microtubule organizing center (Figure S8). The close associ-
ation of the CCV and the Golgi does not represent a default
pathway for any internalized particle traveling to a perinu-
clear position since internalized S. typhimurium invA (invasin)
did not show association to the Golgi despite the fact that
these phagosomes were also located in a perinuclear region
(Figure 8C). Electron microscopy analysis conﬁrmed the
Figure 5. The C. jejuni–Containing Vacuole Acquires Markers of the Early and Late Endocytic Pathway but Not of Lysosomes
Cos-1 cells were infected with C. jejuni and or S. typhimurium invA (invasin), as indicated. At the designated times, cells were fixed and processed for
immunofluorescence using antibodies directed to C. jejuni or S. typhimurium and to the endocytic markers EEA-1 and lamp-1 (A and B), or cathepsin B (G
and H). Alternatively, Cos-1 cells were transfected with plasmids expressing PX-GFP (a probe for phosphoinositide 3 phosphate) (C), Rab4-GFP (D), Rab5-
GFP (E), or Rab7-GFP (F) , and subsequently infected with C. jejuni or S. typhimurium invA (invasin) as indicated. Cells were fixed and processed for
immunofluorescence using antibodies directed to C. jejuni or S. typhimurium. At the indicated times, the number of bacteria-containing vacuoles that
colocalized with the different markers was quantified by immunofluorescence microscopy as indicated in Materials and Methods. Results are the means
and standard deviation of three independent experiments. For each experiment at least 100 vacuoles were counted for acquisition of each marker.
doi:10.1371/journal.ppat.0040014.g005
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C. jejuni Intracellular Survivalintimate association of the CCV and the Golgi apparatus
(Figure 8D). However, the CCV did not acquire Golgi markers
(data not shown), indicating that despite their close associ-
ation, the two compartments remain distinct.
We then investigated the mechanism by which the CCV
reaches its perinuclear destination. Many intracellular bac-
teria in membrane-bound compartments trafﬁc along micro-
tubule tracks to reach their destination within the cell. We
ﬁrst investigated the role of microtubules in the localization
of the CCV. When nocodazole was added to disrupt the
microtubule network after infection of Cos-1 cells, the CCVs
were observed distributed throughout the cell and did not
reach a perinuclear location (Figure 8F). These data show that
intact microtubules are necessary for the CCV to reach its
ﬁnal destination. Phagosomes most often move along micro-
tubules through the action of speciﬁc motors [57,58].
Cytoplasmic dynein is a minus-end directed motor that is
responsible for moving cargo away from the periphery and
toward the microtubule organizing center [59] and is there-
fore a candidate motor to move the CCV to its ﬁnal
destination. We investigated this hypothesis by overexpress-
ing GFP-dynamatin p50, a subunit of the dynactin complex
that when overexpressed, blocks the function of dynein [60].
Immunoﬂuorescence analysis showed that overexpression of
dynamatin p50 effectively disrupts the localization of C. jejuni
at 6 h post-infection (Figure 8G). These results are consistent
with a previous observation indicating that addition of
orthovanadate, a rather non-speciﬁc inhibitor of dynein,
inhibits the movement of the CCV to a perinuclear position
[56]. Taken together, these results indicate that subsequent to
internalization, the CCV travels to a perinuclear position in
the immediate vicinity of the Golgi apparatus and that the
movement of the CCV requires both microtubules and the
molecular motor dynein.
Discussion
Similar to other enteric pathogens, C. jejuni has evolved the
ability to gain intracellular access to non-phagocytic intesti-
nal epithelial cells and this process has been implicated in
pathogenesis [7,14,20,61,62]. Although most work to date has
focused on C. jejuni entry into host cells, the intracellular fate
of this pathogen has been largely uncharacterized. We have
shown here that C. jejuni survives within intestinal epithelial
cells, although over time it acquires a metabolic state that
renders it unculturable under standard culture conditions.
However, C. jejuni recovered from within epithelial cells could
be cultured if subjected to conditions of severe oxygen
limitation. These results suggest that once within epithelial
cells, C. jejuni may either become oxygen sensitive or may alter
its respiration mode so that it can no longer be cultured in
the presence of oxygen. The recently completed nucleotide
sequence of the genome of the C. jejuni strain 81–176 used in
this study revealed the presence of genes involved in
additional respiratory pathways, including electron acceptors
that may be utilized for alternate modes of respiration [63].
Thus, these additional respiration genes may contribute to
the ability of C. jejuni 81–176 to survive within intestinal
epithelial cells.
We showed here that C. jejuni survives within intestinal
epithelial cells within a compartment that is distinct from
lysosomes (Figure 9). CCVs are not accessible to endocytic
tracers indicating that they are functionally separated from
described endocytic pathways leading to lysosomes. In fact,
when targeted into lysosomes after internalization via the Fc
receptor, C. jejuni was unable to survive within epithelial cells.
These results indicate that C. jejuni has evolved speciﬁc
adaptations to trafﬁc within host cells and avoid delivery into
lysosomes. These adaptations may be important to faciliate
colonization of the host by providing a safe-heaven where C.
jejuni can avoid innate immune defense mechanisms. How-
ever, those adaptations must not be able to operate in
macrophages since, in these cells, C. jejuni is targeted to
lysosomes and therefore cannot survive.
Our results suggest that C. jejuni deviates from the canon-
ical endocytic pathway shortly after internalization (Figure 9).
The CCV appears to interact with early endosomal compart-
ments since it associates with early endosomal markers such
as EEA-1, Rab5, Rab4, and PX-GFP (which labels PI3P).
However, this interaction is transient and does not lead to
progression within the canonical endocytic pathway. The
presence of markers of lipid-associated rafts and caveolae on
the CCV suggests that C. jejuni may reside in a compartment
that is functionally distinct from early endosomes. In fact, C.
jejuni was still able to target properly in the presence of
Figure 6. Dominant-Negative Rab5 and Rab7 Do Not Block Acquisition of lamp-1 by the C. jejuni–Containing Vacuole
Cos-1 cells were transfected with plasmids expressing either Rab5-GFP, Rab7-GFP, or the dominant negative mutants Rab5
S34N-GFP or Rab7
N125I-GFP.
Twenty-four hours after transfection, cells were infected with C. jejuni or S. typhimurium invA (invasin) for 15 min followed by a 1 h gentamicin chase.
Cells were fixed, and lamp-1 acquisition was assessed after processing for immunofluorescence using anti-C. jejuni or anti-S. typhiumurium and lamp-1
antibodies. Results are the means and standard deviation of three independent experiments. For each experiment, at least 100 vacuoles were counted
for colocalization with lamp-1.
doi:10.1371/journal.ppat.0040014.g006
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early events in the endocytic pathway [43].
C. jejuni has unusual cytoskeletal requirements to gain
intracellular access to intestinal epithelial cells since its
internalization is dependent on microtubules but not on the
actin cytoskeleton [10], as is usually the case for most
intracellular bacteria [22]. Consistent with previous observa-
tions suggesting that caveolae are required for C. jejuni entry
[44,45], we have shown here that bacterial internalization is
dependent on caveolin-1. However, we showed that the entry
process is independent of dynamin, whose function is
essential for clathrin and caveolae-mediated endocytosis
[51–53]. In fact, expression of a dominant-inhibitory form
of dynamin resulted in a reproducible increase in the ability
of C. jejuni to enter cells. We therefore hypothesize that a
caveolin-1-stabilized lipid membrane domain may be re-
quired for proper signaling through tyrosine kinases, which
are also required for C. jejuni internalization rather than for
endocytosis. In fact, efﬁcient signaling through receptor
tyrosine kinases requires lipid rafts or caveolae [64,65] and
Figure 7. Caveolin Is Recruited to the C. jejuni–Containing Vacuole and Is Required for Efficient C. jejuni Entry Into Epithelial Cells
Cos-1 cells were transfected with plasmids expressing caveolin-1-GFP or flotillin-1-GFP. Twenty-four hours after transfection, cells were infected with C.
jejuni, fixed at the designated time points, and processed for immunofluorescence using a staining protocol that distinguishes extracellular from
internalized bacteria. Images corresponding to 15 min after infection show colocalization of (A) caveolin-1-GFP (green) (A) and flotillin-1-GFP (green) (B)
with intracellular C. jejuni (red). The colocalization of C. jejuni with caveolin-1-GFP (C) or flotillin-1-GFP (D) was quantified at the indicated times after
infection as described in Materials and Methods. Results are the means and standard deviation of three independent experiments. For each experiment,
at least 100 vacuoles were counted for colocalization with each marker for each time point. In addition, Cos-1 cells were transfected with plasmids
expressing caveolin-1-GFP, dynamin II-GFP, or their dominant negative mutants caveolin-1
Y14F-GFP or dynaminII
K44A-GFP (E and F). Twenty-four hours
after transfection, cells were infected with C. jejuni, fixed, internalized bacteria were quantified 3 h after infection as described in the Materials and
Methods. The values are the mean and standard deviation of three independent experiments and are expressed as a percentage of the control
(caveolin-1-GFP and dynaminII-GFP, respectively), which was considered to be 100%. For each experiment the number of intracellular bacteria was
determined for at least 50 transfected cells. The difference between the levels of internalization in cells expressing wild type and dominant-negative
mutant forms of caveolin or dynamin were significantly different (unpaired t-test p ¼ 0.02 for both sets of samples).
doi:10.1371/journal.ppat.0040014.g007
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[66]. In this context, we hypothesize that the enhancement of
C. jejuni internalization observed when inhibiting dynamin
function, may be the result of an increase in the availability of
putative surface ‘‘receptor’’ for this pathogen resulting in
enhanced signaling for entry.
What is the nature of the CCV? We showed that the CCV
contains lamp-1, although this compartment is unique and
clearlydistinctfromlysosomessinceitdoesnotcolocalizewith
the lysosomal protein marker cathepsin B and it is not
accessible to endocytic tracers. In fact, the acquisition of
lamp-1, which occurs very early in the CCV maturation, must
occur by an unusual mechanism that does not require the
GTPases Rab5 or Rab7. Interestingly, S. typhimurium resides
within a vacuole that is apparently segregated from the
canonical endocytic pathway [27,67] and also harbors lamp-
1, although in this case acquisition of this marker appears to
require Rab7 [68]. Another unique property of the CCV is its
close association with the Golgi, which requires microtubules
andthemotorprotein dynein.Morestudieswillberequired to
better deﬁne the nature of this compartment and the precise
mechanisms by which C. jejuni modulates vesicular trafﬁcking.
Figure 8. The C. jejuni–Containing Vacuole Localizes in Close Proximity to the Golgi
Cos-1 cells were infected with C. jejuni or S. typhimurium invA (invasin) expressing dsRed for 1 h followed by a gentamicin chase. Cells were fixed at the
designated times after infection and processed for immunofluorescence using anti-C. jejuni (red) and anti-GM-130 antibodies (green). Nuclei were
visualized with DAPI (blue). Immunofluorescence images of C. jejuni-infected cells 2 h (A) and 6 h (B) post-infection, and S. typhiumurium invA (invasin)-
infected cells 6 h post-infection (C). (D) Electron micrograph of C. jejuni-infected cells 6 h post-infection. (E) Quantitation of C. jejuni association with the
Golgi at different times after infection. Values are averages and standard deviations of three independent experiments. A minimum of 100 infected cells
were counted in each experiment (F) Nocodazole treatment prevents C. jejuni’s close association with the Golgi. Cos-1 cells were infected with C. jejuni
for 1 h and after a 1 h gentamicin chase, cells were treated with nocodazole for additional 4 h to disrupt microtubules. At 6 h after infection, cells were
fixed and processed for immunofluorescence as described above. (G) Dymanin is required for the localization of C. jejuni in close association to the
Golgi. Cos-1 cells were transfected with dynamatin p50-GFP and 24 h later, cells were infected with C. jejuni as described above. Six hours after infection,
cells were fixed and processed for immunoflourecesce using anti-C. jejuni and anti GM-130 antibodies.
doi:10.1371/journal.ppat.0040014.g008
PLoS Pathogens | www.plospathogens.org January 2008 | Volume 4 | Issue 1 | e14 0078
C. jejuni Intracellular SurvivalIn summary, we have established that C. jejuni has evolved
speciﬁc adaptations to survive within intestinal epithelial
cells by avoiding delivery into lysosomes. This survival
strategy does not appear to operate in BMDM since C. jejuni
is rapidly killed in these cells. We hypothesize that C. jejuni’s
unusual entry mechanism may be central to its ability to
avoid delivery into lysosomes since when internalized via a
different pathway (e.g., via the Fc receptor), C. jejuni could not
avoid delivery into lysosomes. Its diversion from a pathway
leading to lysosomes must therefore occur upon entry.
Understanding the mechanism by which this bacterium
survives within host cells may provide new insights into C.
jejuni pathogenesis as well as reveal undiscovered paradigms
in host cellular trafﬁcking.
Materials and Methods
Bacterial strains, culture conditions, and plasmids. Wild-type C.
jejuni 81–176 has been described previously [69]. C. jejuni were
routinely grown on tryptic soy broth agar supplemented with 5%
sheep blood (BA) or in brain heart infusion (BHI) broth at 37 8C
under 10% CO2, or where indicated, in an anaerobic chamber under
low oxygen conditions (BD-Diagnostic Systems GasPak Plus Anaero-
bic System Envelopes with Palladium Catalyst, catalog number
271040, New Jersey), or with BBL CampyPacks (BBL Microbiology
Systems, Cockeysville, MD). S. typhimurium invA has been described
previously [70] and was transformed with invasin-encoding plasmid
pRI203, which mediates mammalian cell entry via ab1 integrins [71].
A S. typhimurium invA strain expressing the dsRed protein was
constructed as follows. The plasmid DsRed.T3_S4T, which expresses
the dsRed protein under the control of an arabinose-inducible
promoter [72], was digested with EcoRI and ScaI to release a fragment
containing dsRed and the paraABC promoter. This fragment was
ligated into pACYC184 and resulting plasmid, pSB3082, was trans-
formed into S. typhimurium invA (pRI203). S. typhimurium invA
expressing invasin and dsRed was routinely grown in LB containing
tetracycline (10 lgm l
 1), ampicillin (50lgm l
 1), and 0.1% arabinose
to induce DsRed expression.
Cell culture and preparation of bone marrow–derived macro-
phages. T84, a human intestinal epithelial cell line, and Cos-1, a
monkey kidney epithelial cell line, were obtained from the American
Type Culture Collection (Rockville, MD) and were grown in DMEM
supplemented with 10% fetal bovine serum containing penicillin (100
Um l
 1) and streptomycin (50 lgm l
 1). Bone marrow–derived
macrophages (BMDM), were obtained as previously described [73].
Brieﬂy, femurs and tibias were excised and ﬂushed with DMEM
containing 10% fetal bovine serum (FBS), penicillin (100 U ml
 1), and
streptomycin (50 lgm l
 1). Cells were spun down and resuspended in
BMDM differentiation medium [DMEM containing 20% FBS, 30% L-
cell supernatant, penicillin (100 U ml
 1) and streptomycin (50 lg
ml
 1)] and plated onto non-tissue culture treated 10-cm
2 plastic
dishes. The cells were fed fresh BMDM differentiation medium on day
3–4 to allow further differentiation until day 6–7. BMDM were then
seeded in the appropriate tissue culture dishes to be used in infection
experiments.
Bacterial infection of cultured cells. C. jejuni was harvested from a
fresh BA plate and grown in BHI broth under under 10% CO2 until
mid log phase (OD600 ¼ 0.7–0.8). To prepare the inoculum, bacteria
were pelleted at 20,000 3 g in a microfuge for 2 min and directly
resuspended in Hank’s Balanced Salt Solution (HBSS) (Invitrogen).
The inoculum was diluted in HBSS to adjust for different multiplicity
of infections (MOI). Serial dilutions of the inoculum were plated onto
BA plates to determine the number of bacteria. T84 cells were split to
70% conﬂuence (;10
5 cells per well) in a 24 well dish. BMDM were
seeded at 2 3 10
5 cells per well in a 24 wells dish. After washing 3X
with HBSS, T84 cells and macrophages were infected with an MOI of
50 or 20, respectively. The plates were centrifuged at 200 3 g for 5
min to maximize bacteria-cell contact and incubated for 1 or 2 h at 37
8C5 %C O 2. Following the incubation, the monolayers were washed
3X with HBSS and incubated with complete media containing
gentamicin (100 lgm l
 l) for 2 h. This concentration of gentamicin
was found to be optimal to kill extracellular bacteria without
affecting the viability of intracellular bacteria. Plating of the infection
medium determined that no signiﬁcant number of c. f. u. were
detected after this treatment. For experiments involving longer time
points, the media was replaced with complete media containing
gentamicin (10 lgm l
 1). Again, plating of the infection medium
determined that no signiﬁcant number of c. f. u. were present after
this treatment. After 3 additional washes, the infected cells were lysed
at the designated time points and the samples were prepared for
colony forming unit (CFU) determination or FACS analysis. To
quantify the number of intracellular bacteria, cells were lysed in PBS
with 0.1% deoxycholate and the CFU were enumerated after plating
serial dilutions grown at 378C with 10% CO2, or in GasPak jars (BBL
Microbiology Systems, Cockeysville, MD) with BBL CampyPacks (BBL
Microbiology Systems, Cockeysville, MD). For anaerobic incubations,
plates were incubated in an anaerobic chamber with a GasPak (BD-
Diagnostic Systems GasPak Plus-Anaerobic System Envelopes with
Palladium Catalyst, Catalog number 271040, New Jersey) for 48 h and
incubated further at 37 8C with 10% CO2. For immunoﬂuorescence
studies, Cos-1 cells were seeded on glass cover slips in 24 well plates.
C. jejuni was cultured as described above. S. typhimurium invA
expressing invasin was cultured in LB containing ampicillin (30 lg
ml
 1) overnight and subcultured 1:20 for 3 h prior to infection. For
time courses, cells were infected with an MOI of 100 and 50 for C.
jejuni and S. typhimurium invA (invasin), respectively, centrifuged from
5 min at 1,000 3 g to maximize bacteria-host cell contact, and
incubated for an additional 15 min at 37 8C5 %C O 2. Wells were
washed three times in PBS and either ﬁxed in 4% PFA for a 15 min
time point or the media was replaced with DMEM þ 10% FBS with
gentamicin (100 lgm l
 1) to kill the extracellular bacteria and prevent
additional bacterial internalization. At later time points cells were
washed an additional three times in PBS, and ﬁxed in 4%
paraformaldehyde. After 4 h or longer infection times, no signiﬁcant
number of bacteria that had remained extracellular but attached to
the cell were detected using the gentamicin treatment described (i.e.,
initial addition of 100 lg/ml for 2 h and subsequent addtion of 10lg/
ml for the remainder of the experiment, see above) (Figure S9). For
Figure 9. Model for C. jejuni Internalization and Trafficking within
Epithelial Cells
C. jejuni enters intestinal epithelial cell via a microtubule and caveolae-
dependent process. After internalization, the C. jejuni–containing vacuole
transiently acquires different markers of the endocytic pathway and
ultimately survives within a compartment that is functionally separated
from the canonical endocytic pathway, which is represented in this
scheme by S. typhimurium invA (invasin).
doi:10.1371/journal.ppat.0040014.g009
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C. jejuni Intracellular Survivalquantitation of intracellular bacteria in transfected cells, Cos-1 cells
were infected with an MOI of 25 for 1 h as described above. Cells were
washed and incubated for 2 additional hours in DMEM þ 10% FBS
with gentamicin (100 lgm l
 1) to kill the extracellular bacteria and
prevent additional bacterial internalization. The cells were then ﬁxed
and processed for immunoﬂuorescence as described below.
Inhibitors. Where indicated, cells were incubated with Nocodazole
(10 lM), Cytocholasin D (5 lM), Genistein (10 lM and 100 lM),
dissolved in DMSO (Sigma), or methyl-beta cyclodextrin (MbCD)
dissolved in PBS (1mM-10mM) 30 min prior to infection and kept
throughout the duration of the incubation period. All control cells
were treated with the appropriate solvent for the same length of time.
Enumeration of C. jejuni in host cells by ﬂow cytometry. T84 cells
and BMDM from wild-type mice were seeded at density of 10
5 cells
per well on a 24-well dish and infected with an MOI of 50 and 20,
respectively. Following a 1 h incubation at 37 8C and 5% CO2, the
cells were washed with HBSS and DMEM containing 10% FBS and
100 lgm l
 1 gentamicin was added to each well. Cells were washed
again and lysed at the designated time points in 500 ll of 0.05%
sodium deoxycholate in PBS. The cell lysates were collected and
subjected to a low speed spin (1,000 rpm) for 2 min to remove large
cell debris. Supernatants were collected and intracellular bacteria
were isolated by a 2 min high-speed spin (10,000 rpm). The isolated
bacterial pellet was resuspended in 500 ll ﬁlter-sterilized staining
buffer (PBS containing 1mM EDTA and 0.01% Tween). The bacteria
were then stained with the reagents of a cell viability kit (BD
Biosciences, San Jose, CA), which distinguishes live and dead cells by
using a thiazole orange (TO) solution, which stains all bacteria, and
propidium iodide (PI), which only stains dead bacteria. TO and PI
were added to ﬁnal concentrations 53 nM and 11 lM, respectively, in
accordance with the manufacturer’s instructions. After 5 min of
staining, bacteria were pelleted, washed once in PBS, resuspended in
1 ml of PBS and analyzed by ﬂow cytometry. The absolute count of
live/dead bacteria was carried out by addition of 50 ll of a liquid
suspension of a known number of ﬂuorescent beads (supplied in the
kit, BD Biosciences, San Jose, CA) following the manufacturer’s
instructions. Samples were analyzed on a FACS calibur ﬂow
cytometer. TO ﬂuoresces primarily in FL1 and FL2; PI primarily in
FL3. An SSC threshold was used, and cells and beads were gated using
scatter and FL2, which detects the TO ﬂuorescence and therefore the
total bacterial population. In order to best discriminate between live
and dead bacteria, an FL1 versus FL3 plot was used and live and dead
populations were gated within this plot (dead cells, FL3þ; live cells,
FL1þ). To determine the bacterial concentration, the following
equation was used: # events in cell region/ # events in bead region x #
beads/test/test volume 3 dilution factor ¼ concentration of cell
population. A plot was generated after using this equation to
calculate the number of viable bacteria (in triplicate wells) in both
T84 and BMDM at each time point.
Immunoﬂuorescence microscopy. Cos-1 cells were infected as
described above and at the designated time points, cells were washed
three times in PBS and ﬁxed in 4% paraformaldehyde (PFA) for 13
min at room temperature (RT). The ﬁxed cells were washed three
times in PBS and permeabilized by incubating them in PBS
containing 3% non-fat milk and 0.05% saponin (PBS-MS) (Calbio-
chem). Cover slips were incubated in primary antibody diluted in
PBS-MS for 30 min. The cover slips were then washed three times in
PBS and incubated in secondary antibody. After two washes in PBS
and two washes in deionized water, the cover slips were mounted
onto glass slides using Prolong Gold antifade reagent (Molecular
Probes). Images were acquired on a Nikon TGE2000-U Eclipse
inverted microscope ﬁtted with a Micromax Princeton digital camera
controlled by the Metamorph software package, version 6.1 (Univer-
sal Imaging Corp., Downingtown, PA). When needed, inside-out
staining was used to differentiate extracellular from intracellular
bacteria. Brieﬂy, before permeabilization with saponin, extracellular
bacteria were stained with rabbit anti-C. jejuni antiserum in PBS
containing 3% milk followed by Alexaﬂour 350-conjugated anti-
rabbit antibodies (Molecular Probes). Cells were washed three times,
permeabilized, and the total bacterial population was stained with
rabbit anti-C. jejuni followed by Alexaﬂour 594-conjugated mouse
anti-rabbit antibodies (Molecular Probes). After two washes in PBS
and two washes in deionized water, the cover slips were mounted
onto glass slides using Prolong Gold antifade reagent (Molecular
Probes). Where indicated, nuclei stained with DAPI (Invitrogen).
Antibodies. Rabbit antibodies against C. jejuni were obtained by
repeated immunization of rabbits with a mixture of equal amounts of
formaldehyde and heat-killed whole cell C. jejuni. Anti-S. typhimurium
(rabbit) antibodies were purchased from DIFCO Laboratories,
Detroit, Michigan. Mouse monoclonal antibodies against EEA-1,
Lamp-1, beta-tubulin, and GM130 were acquired from BD Bioscien-
ces Pharmingen. A mouse anti cathepsin B antibody was a gift from
the laboratory of Dr. Ira Mellman, Yale University, New Haven, CT.
Secondary antibodies used were: Alexa 596- Alexa-488, Alexa 350-
conjugated goat anti-rabbit and Alexa 596- Alexa 488- Alexa 350-
conjugated goat anti-mouse IgG antiserum (Molecular Probes).
Plasmids and transient transfection. Eukaryotic expression vectors
encoding GFP-tagged wild-type Rab5 and Rab7 as well as their
dominant negative mutants have been previously described [74–76].
GFP-tagged Rab4, PX, dynamin II, dynamin II
K44A, caveolin-1, and
caveolin-1
Y14F as well as murine Fc-receptorII (FcRII) expressing
eukaryotic vectors have been described elsewhere [77–81]. The
human ﬂotillin-1 gene was ampliﬁed from a human cDNAs library
by polymerase chain reaction (PCR) using primers fwd (59-TAGCTC-
GAGCCATGTTTTTCACTTGTGGCCC-39)a n dr e v( 5 9-TCTA-
GAATTCCGGCTGTTCTCAAAGGCTTGA-39). The PCR product
was then cloned into pEGFP-N1 (Clontech, Oxford, UK) using XhoI
and EcoR1. The resulting plasmid, pSB3111, yielded ﬂotillin-1 fused
to the N-terminus of GFP. pFlot1-FLAG was a generous gift from Dr.
Rosanna Paciucci, Unitat de Recerca Biomedica, Barcelona, Spain
[82]. Plasmid DNA was puriﬁed using the Maxiprep kit (Qiagen) and
used for transfection of cells with LipofectAMINE 2000 (Invitrogen)
according to the manufacturers instructions.
Colocalization of markers with the CCV and bacterial quantitation
of transfected cells. To quantitate the percentage of CCV containing
different endocytic ﬂuid tracers or cellular markers, infected cells
were visualized directly in the ﬂuorescence microscope. Using the
Metamorph software package a series of images were taken, including
internalized bacteria, total bacteria, and the cellular marker. Over-
layed ﬂuorescent images were analyzed by determining the number of
CCVs that contained the corresponding marker. A minimum of one
hundred vacuoles was analyzed per cover slip for each treatment and
designated post-infection time. Each experiment was completed in
triplicate wells/cover slips and expressed as an average. CCVs were
considered positive for the presence of a marker when they
contained detectable amounts of the staining probe/antibody. The
same methodology was used to quantitate the number of intracellular
bacteria within transfected cells. Brieﬂy, Cos-1 cells seeded on cover
slips were transfected with plasmids encoding GFP-tagged proteins,
infected, and processed for immunoﬂuorescence. A minimum of 50
transfected cells were randomly selected and imaged as described
above and the number of intracellular bacteria was quantitated
within each cell. Each experiment was completed in triplicate wells/
cover slips and expressed as an average number of bacteria per
transfected cell and where designated normalized to control cells.
Statistical analysis of the results was carried out by the student t-test.
Fluid endocytic tracers and pulse-chase experiments. Cos-1 cells
were grown on coverslips in 24-well dishes and infected with C. jejuni
or S. typhimurium invA (invasin) and dsRed at an MOI of 25 and 10
respectively. After spinning for 5 min at 200 3 g and allowing the
infection to proceed for 1 h, the cells were washed three times and
fresh media containing gentamicin was added to kill the extracellular
bacteria. After an additional 3 h the cells were incubated with Texas
Red or Alexaﬂuor-488 labeled dextran (1 mg/ml; Molecular Probes)
for 1 h. The cells were washed three times and incubated with fresh
media containing gentamicin for an additional 2 h. The cover slips
were then processed for immunoﬂuorescence.
FcR-mediated C. jejuni internalization. Cos-1 cells were plated in a
24 well dish at ;40% conﬂuency and transfected with a plasmid
encoding FcRII [80]. After an overnight incubation, cells were
incubated with C. jejuni that were opsonized with rabbit polyclonal
anti-C. jejuni antibodies (1:1,000). Plates were centrifuged at 200 3 g
for 5 min and incubated at 37 8C5 %C O 2 for 1 h, after which the cells
were washed three times with HBSS, and incubated with complete
media containing gentamicin (100 lgm l
 1). Cells were then lysed at
the designated time points and the number of viable intracellular
bacteria was assessed as described above.
Live cell imaging. Cos-1 cells were grown on life cell imaging dishes
(MatTek Corp.) and transfected with ﬂotillin-1-GFP or PX-GFP [78]
encoded eukaryotic expression vectors as described above. C. jejuni
was cultured as described above and ﬂuorescently labeled using
PKH26 Red Flourescent Cell Linker Kit according to manufacturer’s
instructions (Sigma). The labeling protocol did not affect C.jejuni’s
viability or its ability to enter into non-phagocytic cells (data not
shown). Cells were infected with an MOI of ;100. Time-lapse series
were acquired using a Nikon TGE2000-U Eclipse inverted microscope
ﬁtted with a Micromax Princeton digital camera controlled by the
Metamorph software package, version 6.1 (Universal Imaging Corp.,
Downingtown, PA). Filters allowed the simultaneous detection of GFP
and rhodamnine, respectively. The acquired images were merged as
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using Metamorph. For the ﬂotillin-1-GFP three dimensional movie,
cells transfected with ﬂotillin-1-GFP were infected for 15 min, ﬁxed,
and processed for imunoﬂourescence using inside-out staining. Z-
stacks were acquired using a Zeiss Axio Imager Upright ﬂuorescent
Microscope ﬁtted with an Apotome and the AxioCam MRc5 digital
camera controlled by the Axiovision software package, version 4.2
(Carl Ziess MicroImaging, Inc.). The cropped images were recon-
structed and converted into a 3D QuickTime movie using Axiovision.
Gene silencing by RNAi. Depletion of ﬂotillin-1 was performed
using a pool of three target-speciﬁc 20–25 nucleotide siRNAs
designed to knock down gene expression (Santa Cruz Biotechnology,
Inc., Santa Cruz, CA). The siRNA pool was transfected into Cos-1 cells
using LipfectAMINE 2000 (Invitrogen). To mark transfected cells,
ﬂotillin siRNA was cotransfected with pEGFP-N1 at a ratio of 5:1.
Intracellular bacteria within GFP-expressing cells were quantiﬁed as
described above. RNAi silencing efﬁciency and speciﬁcity were
analyzed at the protein level by Western blot analysis 72 h after
cotransfection of pFlot1-FLAG [82] with the siRNA pool. Protein
depletion by RNAi was normalized to endogenous levels of actin
using rabbit anti-actin antibodies (Sigma-Aldrich).
Electron microscopy. Cos-1 cells or BMDM were plated at
approximately 8 3 10
6 cells on 10 cm
2 plastic tissue culture dishes.
After 3x wash with warm HBSS, C. jejuni, cultured as described above,
were used to infect cells at an MOI of 100. At 1.5 h post-infection, the
extracellular bacteria were washed off three times with warmed HBSS
and the plates were incubated with warmed culture media containing
gentamicin to kill the extracellular bacteria. For standard EM, the
infected cells were incubated at 37 8C5 %C O 2 for and additional 4.5
h. For BSA-gold experiments, after a 3.5 h incubation, the infected
cells were incubated for 1 h with BSA-gold-containing complete
media. After three additional washes cells were ﬁxed in situ with a
freshly made solution of 1% glutaraldehyde (from an 8% stock from
Electron Microscopy Sciences (EMS), Fort Washington, PA) 1% OsO4
in 0.05 M phosphate buffer at pH 6.2 for 45 min. After ﬁxation, the
cells in petri plates were rinsed three times with cold distilled water
and en bloc stained with uranyl acetate overnight. The petri plates
were then dehydrated in ethanol then placed into hydroxypropyl
methacrylate (EMS), which does not react with the plastic in the petri
dish, and embedded in L 112, an epon substitute (Ladd, Burlington,
VT). Following polymerization of the epon, the block was cut out and
mounted and thin sections were cut through their exposed surfaces.
Thin sections were collected on naked grids stained with uranyl
acetate and lead citrate and examined in a Philips 200 electron
microscope. At least ﬁfty vacuoles were analyzed for the presence of
BSA-gold for each condition.
Supporting Information
Figure S1. The C. jejuni–Containing Vacuole Is Not Accessible to the
Endocytic Tracer Dextran
Found at doi:10.1371/journal.ppat.0040014.sg001 (5.0 MB TIF).
Figure S2. Acquisition of EEA-1 and lamp-1 by the C. jejuni–
Containing Vacuole
Found at doi:10.1371/journal.ppat.0040014.sg002 (4.2 MB TIF).
Figure S3. The C. jejuni–Containing Vacuole Acquires Markers of the
Early Endocytic Pathway
Found at doi:10.1371/journal.ppat.0040014.sg003 (8.3 MB TIF).
Figure S4. The C. jejuni–Containing Vacuole Acquires Rab7 but Not
Cathepsin B
Found at doi:10.1371/journal.ppat.0040014.sg004 (8.2 MB TIF).
Figure S5. Dominant-Negative Rab5 and Rab7 Do Not Block
Acquisition of lamp-1 by the C. jejuni–Containing Vacuole
Found at doi:10.1371/journal.ppat.0040014.sg005 (11.9 MB TIF).
Figure S6. C. jejuni Internalization into Cultured Intestinal Epithelial
Cells in the Presence of Different Host Cell Inhibitors
Found at doi:10.1371/journal.ppat.0040014.sg006 (11.9 MB TIF).
Figure S7. Flotillin-1 Is Not Essential for C. jejuni Internalization into
Epithelial Cells
Found at doi:10.1371/journal.ppat.0040014.sg007 (2.0 MB TIF).
Figure S8. Intracellular Campylobacter jejuni Localizes in Close
Proximity to the Microtubule-Organizing Center
Found at doi:10.1371/journal.ppat.0040014.sg008 (926 KB TIF).
Figure S9. Absence of Extracellular Bacteria after Gentamicin
Treatment
Found at doi:10.1371/journal.ppat.0040014.sg009 (415 KB TIF).
Video S1. C. jejuni Recruitment of PX-GFP
Found at doi:10.1371/journal.ppat.0040014.sv001 (1.2 MB MOV).
Video S2. Colocalization of C. jejuni with Flotillin-1-GFP
Found at doi:10.1371/journal.ppat.0040014.sv002 (489 KB MOV).
Video S3. C. jejuni Recruitment of Flotillin-GFP
Found at doi:10.1371/journal.ppat.0040014.sv003 (2.6 MB MOV).
Video S4. Flotillin-1-GFP Dynamics during C. jejuni Infection
Found at doi:10.1371/journal.ppat.0040014.sv004 (3.4 MB MOV).
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